These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology. Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death. Divakaruni AS; Wallace M; Buren C; Martyniuk K; Andreyev AY; Li E; Fields JA; Cordes T; Reynolds IJ; Bloodgood BL; Raymond LA; Metallo CM; Murphy AN J Cell Biol; 2017 Apr; 216(4):1091-1105. PubMed ID: 28254829 [TBL] [Abstract][Full Text] [Related]
5. Decreased Mitochondrial Pyruvate Transport Activity in the Diabetic Heart: ROLE OF MITOCHONDRIAL PYRUVATE CARRIER 2 (MPC2) ACETYLATION. Vadvalkar SS; Matsuzaki S; Eyster CA; Giorgione JR; Bockus LB; Kinter CS; Kinter M; Humphries KM J Biol Chem; 2017 Mar; 292(11):4423-4433. PubMed ID: 28154187 [TBL] [Abstract][Full Text] [Related]
6. Nrf2 activation through the PI3K/GSK-3 axis protects neuronal cells from Aβ-mediated oxidative and metabolic damage. Sotolongo K; Ghiso J; Rostagno A Alzheimers Res Ther; 2020 Jan; 12(1):13. PubMed ID: 31931869 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial pyruvate carrier 2 mediates mitochondrial dysfunction and apoptosis in high glucose-treated podocytes. Feng J; Ma Y; Chen Z; Hu J; Yang Q; Ding G Life Sci; 2019 Nov; 237():116941. PubMed ID: 31606382 [TBL] [Abstract][Full Text] [Related]
9. ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer's Disease. Patro S; Ratna S; Yamamoto HA; Ebenezer AT; Ferguson DS; Kaur A; McIntyre BC; Snow R; Solesio ME Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681851 [TBL] [Abstract][Full Text] [Related]
18. The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters. Nancolas B; Guo L; Zhou R; Nath K; Nelson DS; Leeper DB; Blair IA; Glickson JD; Halestrap AP Biochem J; 2016 Apr; 473(7):929-36. PubMed ID: 26831515 [TBL] [Abstract][Full Text] [Related]
19. The Key Roles of GSK-3β in Regulating Mitochondrial Activity. Yang K; Chen Z; Gao J; Shi W; Li L; Jiang S; Hu H; Liu Z; Xu D; Wu L Cell Physiol Biochem; 2017; 44(4):1445-1459. PubMed ID: 29190615 [TBL] [Abstract][Full Text] [Related]
20. The Multifaceted Pyruvate Metabolism: Role of the Mitochondrial Pyruvate Carrier. Zangari J; Petrelli F; Maillot B; Martinou JC Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]